Key result
Severe renal impairment independently increased all-cause death compared to CrCl ≥80 mL/min in patients with non-valvular atrial fibrillation.
Why the study?
Does renal impairment increase the risk of adverse clinical outcomes in patients with non-valvular atrial fibrillation?
Observational (n=6,052)
Yes
Does renal impairment increase the risk of adverse clinical outcomes in patients with non-valvular atrial fibrillation?
Renal impairment is an independent predictor of thromboembolism and all-cause mortality in Japanese patients with non-valvular atrial fibrillation.
Answers are grounded in this paper and cite their sources.
Renal impairment assessment refines mortality prediction in non-valvular AF; extends risk stratification data but leaves open therapeutic implications.
Aims: To clarify the influence of renal function on adverse outcomes in patients with non-valvular atrial fibrillation (NVAF), a post hoc analysis of the J-RHYTHM Registry was performed. Methods and results: A consecutive series of outpatients with atrial fibrillation (AF) were enrolled from 158 institutions and followed for 2 years or until the occurrence of an event. Among 7406 patients with non-valvular AF, 6052 patients (69.8 ± 10.0 years, 71.2% men) with creatinine clearance (CrCl) value at baseline were divided into four groups according to CrCl level (<30, 30-49.9, 50-79.9, and ≥80 mL/min). Patients with CrCl <80 mL/min showed increased incidence of thromboembolism, major haemorrhage, all-cause and cardiovascular death, and composite events as compared with patients with CrCl ≥80 mL/min. After adjustment for multiple confounders, lower CrCl values emerged as independent predictors for thromboembolism [CrCl 30-49.9, hazard ratio (HR) 2.27, 95% confidence interval (CI) 1.09-4.72, P = 0.029; and CrCl 50-79.9, HR 1.99, 95% CI 1.07-3.72, P = 0.030] and all-cause death (CrCl <30, HR 6.44, 95% CI 3.03-13.7, P < 0.001; and CrCl 30-49.9, HR 3.14, 95% CI 1.54-6.41, P = 0.002), with CrCl ≥80 mL/min serving as a reference, whereas not for major haemorrhage. Warfarin treatment was associated with lower rates of composite events in patients with lower CrCl values of <80 mL/min. Conclusion: Renal impairment was an independent predictor of adverse clinical outcomes except for major haemorrhage in Japanese patients with non-valvular AF. Warfarin was associated with lower rates of composite events in patients with lower CrCl values. Clinical Trial Registration: http://www.umin.ac.jp/ctr/. Unique identifier: UMIN000001569.
No takes yet. Share an insight, caveat, or question.
Kodani et al. (2017) conducted an observational in Non-valvular atrial fibrillation (n=6,052). Severe renal impairment (Creatinine clearance <30 mL/min) vs. Normal renal function (Creatinine clearance ≥80 mL/min) was evaluated on All-cause death (HR 6.44, 95% CI 3.03-13.7, p=<0.001). Severe renal impairment independently increased all-cause death compared to CrCl ≥80 mL/min in patients with non-valvular atrial fibrillation.
Synapse has enriched 10 related papers. Consider them for comparative context: